UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D. C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15 (d) of
the Securities Exchange Act of 1934
Date of Report: June 30, 2003
(Date of earliest event reported)
VASOMEDICAL, INC.
(Exact name of registrant as Specified in its Charter)
Delaware 0-18105 11-2871434
---------- --------- ------------
(State or other jurisdiction of Commission (I.R.S. Employer
incorporation or organization) File Number) Identification Number)
180 Linden Avenue, Westbury, New York 11590
------------------------------------- -----
(Address of Principal Executive Offices) (Zip Code)
Registrant's Telephone Number, Including Area Code (516) 997-4600
-------------
--------------------------------------------------------------------------------
(Former name or former address, if changed since last report.)
Item 5. Other Events
Effective June 30, 2003, Gregory Cash was appointed Chief Executive Officer
and a director of the Company. At the same time, the Company entered into a
modification of his Employment Agreement. Mr. Cash has also retained the
position of President.
Item 7. Financial Statements, Pro Forma Financial Information and Exhibits.
(c) Exhibits
10 Modification to Employment Agreement between the Company and
Gregory Cash dated as of June 30, 2003.
SIGNATURE
---------
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
VASOMEDICAL, INC.
By: /s/ Joseph A. Giacalone
-----------------------
Joseph A. Giacalone
Chief Financial Officer
Dated: July 3, 2003